Cell Reports (Feb 2014)

E3 Ubiquitin Ligase Cbl-b Suppresses Proallergic T Cell Development and Allergic Airway Inflammation

  • Guilin Qiao,
  • Haiyan Ying,
  • Yixia Zhao,
  • Yanran Liang,
  • Hui Guo,
  • Huifeng Shen,
  • Zhenping Li,
  • Julian Solway,
  • Enxiang Tao,
  • Y. Jeffrey Chiang,
  • Stanley Lipkowitz,
  • Josef M. Penninger,
  • Wallace Y. Langdon,
  • Jian Zhang

DOI
https://doi.org/10.1016/j.celrep.2014.01.012
Journal volume & issue
Vol. 6, no. 4
pp. 709 – 723

Abstract

Read online

E3 ubiquitin ligase Cbl-b has emerged as a gatekeeper that controls the activation threshold of the T cell antigen receptor and maintains the balance between tolerance and autoimmunity. Here, we report that the loss of Cbl-b facilitates T helper 2 (Th2) and Th9 cell differentiation in vitro. In a mouse model of asthma, the absence of Cbl-b results in severe airway inflammation and stronger Th2 and Th9 responses. Mechanistically, Cbl-b selectively associates with Stat6 upon IL-4 ligation and targets Stat6 for ubiquitination and degradation. These processes are heightened in the presence of T cell receptor (TCR)/CD28 costimulation. Furthermore, we identify K108 and K398 as Stat6 ubiquitination sites. Intriguingly, introducing Stat6 deficiency into Cblb−/− mice abrogates hyper-Th2 responses but only partially attenuates Th9 responses. Therefore, our data reveal a function for Cbl-b in the regulation of Th2 and Th9 cell differentiation.